Explore
Validate
LearnNB100-684
antibody from Novus Biologicals
Targeting: GZMB
CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NB100-684 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NB100-684, RRID:AB_10001094
- Product name
- Rabbit Polyclonal Granzyme B Antibody
- Antibody type
- Polyclonal
- Description
- Affinity purified. This reacts with a 32 kDa protein.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.5 ml
- Storage
- Store at 4C. Do not freeze.
Submitted references High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model.
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.
Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy.
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.
Luchtel RA, Bhagat T, Pradhan K, Jacobs WR Jr, Levine M, Verma A, Shenoy N
Proceedings of the National Academy of Sciences of the United States of America 2020 Jan 21;117(3):1666-1677
Proceedings of the National Academy of Sciences of the United States of America 2020 Jan 21;117(3):1666-1677
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.
Giles AJ, Hao S, Padget M, Song H, Zhang W, Lynes J, Sanchez V, Liu Y, Jung J, Cao X, Fujii R, Jensen R, Gillespie D, Schlom J, Gilbert MR, Nduom EK, Yang C, Lee JH, Soon-Shiong P, Hodge JW, Park DM
JCI insight 2019 Oct 17;4(20)
JCI insight 2019 Oct 17;4(20)
Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy.
Medler TR, Murugan D, Horton W, Kumar S, Cotechini T, Forsyth AM, Leyshock P, Leitenberger JJ, Kulesz-Martin M, Margolin AA, Werb Z, Coussens LM
Cancer cell 2018 Oct 8;34(4):561-578.e6
Cancer cell 2018 Oct 8;34(4):561-578.e6
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer.
Gunderson AJ, Kaneda MM, Tsujikawa T, Nguyen AV, Affara NI, Ruffell B, Gorjestani S, Liudahl SM, Truitt M, Olson P, Kim G, Hanahan D, Tempero MA, Sheppard B, Irving B, Chang BY, Varner JA, Coussens LM
Cancer discovery 2016 Mar;6(3):270-85
Cancer discovery 2016 Mar;6(3):270-85
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Granzyme B Antibody [NB100-684] - FFPE human tonsil stained with Granzyme B antibody.
